Healthy volunteers help test new high blood pressure drug combo
NCT ID NCT06884085
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 24 times
Summary
This early-stage study tested a new drug called AD-227 in 70 healthy adults to see how the body processes it and if it is safe. Participants received a single dose of either the combined drug or its two parts separately. The goal was to gather information, not to treat high blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.